Why is "Roquefort" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-05 09:15:55
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Roquefort is a sheep-milk blue cheese from southern France. Though, within differences between legal roqueforts, indistinguishable cheeses are produced elsewhere, EU law dictates that only those cheeses aged in the natural Combalou caves of Roquefort-sur-Soulzon may bear the name "Roquefort", as it is a recognised geographical indication, and has a protected designation of origin.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Gross margin % of Roquefort Therapeutics plc – LSE:COIL - TradingView
-
Roquefort Therapeutics (COIL) Insider Trading Activity 2026 $COIL - MarketBeat
-
Roquefort Therapeutics (COIL) Earnings Date and Reports 2026 $COIL - MarketBeat
-
Roquefort Therapeutics plc Earnings and Revenue – LSE:COIL - TradingView
-
Roquefort Therapeutics Acquires Global Rights to TACC3 Inhibitor AO-252 in £31.9M Deal, Pivoting to Clinical-Stage Oncology - Oncodaily
-
Roquefort Therapeutics plc Financial Statements – FWB:0AG0 - TradingView
-
Roquefort Therapeutics (FRA:0AG0) Cyclically Adjusted Price - gurufocus.com
-
Roquefort Therapeutics (COIL) Stock Chart and Price History 2026 $COIL - MarketBeat
-
Coiled Therapeutics' Dr Sotirios Stergiopoulos on Roquefort RTO, AO-252 cancer trial update - Yahoo Finance
-
Roquefort Therapeutics to acquire cancer drug licence in £32m RTO deal and raise £8.5m - Yahoo Finance UK
-
Volume of Roquefort cheese produced in France from 2008 to 2023 - Statista
-
Preferred dividends of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Book value per share of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Total debt per share of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Current ratio of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Preferred dividends of Roquefort Therapeutics plc – FWB:0AG0 - TradingView
-
Pretax income of Roquefort Therapeutics plc – FWB:0AG0 - TradingView
-
Discontinued operations of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Discontinued operations of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Return on invested capital % of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Long term debt to total equity ratio of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Return on assets % of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
EBITDA per share of Roquefort Therapeutics plc – DUS:0AG0 - TradingView
-
Equity in earnings of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Free cash flow per share of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Free cash flow per share of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
EBIT per share of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Current ratio of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Price to book ratio of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Operating cash flow per share of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Taxes of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Debt to assets ratio of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Net income of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Cash from investing activities of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Return on equity % of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
EBITDA of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Average basic shares outstanding of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Return on invested capital % of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Diluted net income available to common stockholders of Roquefort Therapeutics plc – FWB:0AG0 - TradingView
-
Dilution adjustment of Roquefort Therapeutics plc – FWB:0AG0 - TradingView
-
Price to cash flow ratio of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Diluted shares outstanding of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Gross profit of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Non-operating income (total) of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Diluted shares outstanding of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Roquefort Extends Deadlines for Lyramid Sale and MK Cell Licensing Deal - TipRanks
-
Price to cash flow ratio of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Cost of goods sold of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Debt to equity ratio of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Enterprise value to EBITDA ratio of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Quick ratio of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Long term debt to total equity ratio of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
EBITDA margin % of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Asset turnover of Roquefort Therapeutics plc – DUS:0AG0 - TradingView
-
Debt to assets ratio of Roquefort Therapeutics plc – DUS:0AG0 - TradingView
-
Non-operating income (total) of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
EBITDA of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Enterprise value of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Return on equity % of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Diluted earnings per share (diluted EPS) of ROQUEFORT THERAP. LS -,01 – FWB:0AG0 - TradingView
-
Gross margin % of Roquefort Therapeutics plc – FWB:0AG0 - TradingView
-
Total common shares outstanding of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Total operating expenses of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
CapEx per share of Roquefort Therapeutics plc – FWB:0AG0 - TradingView
-
Debt to equity ratio of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
ROQUEFORT THERAP. LS -,01 Dividends – DUS:0AG0 - TradingView
-
Diluted earnings per share (diluted EPS) of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
EBIT of ROQUEFORT THERAP. LS -,01 – DUS:0AG0 - TradingView
-
Maison Gabriel Coulet Roquefort Recalled in Canada For Listeria - Food Poisoning Bulletin
-
Roquefort Shareholders Back AO-252 Deal and £8.5m Fundraise Ahead of AIM Switch - TipRanks
-
Roquefort Therapeutics Rebrands as Coiled Therapeutics After AO-252 Licence Deal - TipRanks
-
Coiled Therapeutics Inc. completed the acquisition of Roquefort Therapeutics plc in a reverse merger transaction. - MarketScreener
-
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video) - DirectorsTalk Interviews
-
Roquefort Theraptcs. - Result of General Meeting - Research Tree
-
Brand of Roquefort cheese recalled due to listeria concerns - CityNews Ottawa
-
Brand of Roquefort cheese recalled due to listeria concerns - CityNews Toronto
-
Macron is facing a Roquefort revolution - spectator.com
-
Roquefort Therapeutics plc plans transformational acquisition into clinical stage biotech company (LON:ROQ) - DirectorsTalk Interviews
-
Camille Giai of Château Roquefort: "White Bordeaux is enjoying a renaissance" - Falstaff
-
Roquefort cheese's 100-year anniversary curdled by industrial monopoly and declining sales - lemonde.fr
-
Cheese recalled in Canada because government testing showed Listeria - Food Safety News
-
Roquefort cheese from Maison Gabriel Coulet recalled due to possible Listeria concern - Toronto Star
-
The Salad Nashville Has Been Craving For Over A Century - Southern Living
-
Roquefort jumps after securing global rights to cancer drug AO-252 - Proactive Investors
-
Teenager becomes youngest mayor in Alpes-Maritimes after shock win - Riviera Radio
-
Roquefort cheese from Maison Gabriel Coulet recalled due to possible Listeria concern - Times Colonist
-
Roquefort Therapeutics slips as Coiled deal amended - Proactive financial news
-
Prince Albert II visits Roquefort-les-Pins to mark historic Grimaldi links - monacolife.net
-
Albert II welcomed in Roquefort-les-Pins - La Gazette de Monaco
-
Roquefort cheese from Maison Gabriel Coulet recalled due to possible Listeria concern - CP24
-
Roquefort, Stilton or Gorgonzola: Which blue cheese is the healthiest? - The Telegraph
-
Roquefort jumps 51% on deal to buy US cancer drug developer | AIM:COIL - Proactive Investors
-
Roquefort Is the Blue Cheese that Tastes Like an Unshowered Crust Punk - VICE
-
Roquefort shares tumble after strong start as investors weigh Lyramid delay - Proactive Investors
-
How Much Longer Will Roquefort Reign as the King of Cheese? - Smithsonian Magazine
-
Here's How You Can Use Blue Cheese To Take Savory Foods To Another Level - Chowhound
-
Is There Truly A Best Time Of Year To Enjoy Pungent Roquefort Cheese? - Chowhound
-
Roquefort Therapeutics FTSE AIM Focused Update Reflecting Sector Developments - Kalkine Media
-
From Roquefort to Munster: A new ‘Cheese Experience’ opens in Paris - The Connexion
-
Roquefort springs over to AIM from Main Market as Coiled Therapeutics - London South East
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.